FDA Inspection 1319110 — SGS Lab Simon

SGS Lab Simon — FEI 3004186644

The FDA completed an inspection of SGS Lab Simon on February 16, 2026 in Wavre. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 16, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Wavre (Belgium)